What biotrial neuroscience does

Biotrial was founded in 1989 and is a privately held, full-service contract research organization headquartered in Rennes, France. It serves biotechnology and pharmaceutical sponsors with nonclinical pharmacology and safety studies, Phase I studies in healthy volunteers and specialized populations, patient and oncology trial management, bioanalysis, biometrics, electronic data capture, biostatistics, pharmacovigilance, regulatory affairs, ECG, CNS testing, EEG and polysomnography, medical imaging, and data science.\n\nBiotrial reports 150 Phase I beds in Rennes and 110 in Newark, New Jersey, for 260 beds in total. It also reports hundreds of studies annually, approximately 10,000 bioanalysis samples per month, and experience managing more than 50 patient trials in over 20 countries during the past five years. Its operating stack combines purpose-built clinical facilities and specialist laboratories with Medidata Rave, implemented in 2015, Clincase, SafetyEasy, Watson LIMS, CDISC standards, and OMOP capabilities. Biotrial also describes a proprietary PEPSY cognitive-testing platform, LC-MS/MS systems, central EEG and cardiac-safety services, and AI, NLP, deep-learning, and generative-AI tools used in SAS, R, and Python for pharmacometrics, in-silico trials, and real-world data analysis.\n\nBiotrial generates revenue through customized CRO projects, with pricing determined by study scope, complexity, therapeutic area, duration, and geographic requirements. It reaches sponsors through direct enterprise sales and assigns multidisciplinary project teams that support studies from protocol design through data management, analysis, and regulatory submission. Public pricing, backlog, customer-level revenue, and named customer portfolios are not available.

Name

biotrial neuroscience

Legal name

Biotrial

Website

https://biotrial.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

251–500 employees

Short description

Biotrial is a private, full-service CRO serving biotechnology and pharmaceutical sponsors with preclinical, Phase I, patient-trial, bioanalytical, biometrics, Core Lab, regulatory, and data-science services across Europe and North America through purpose-built clinical units and specialist facilities.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

• Contract research organization
• Clinical trial services
• Preclinical drug development
• Bioanalytical services
• Central laboratory services

Headquarters

HQ city

Rennes

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Research Organization (CRO) Services: Biotrial generates revenue through comprehensive contract research services spanning non-clinical pharmacology, clinical development (Phase I studies with healthy volunteers and patients), bioanalysis, biometrics, Core Lab services, and data science. Services are provided on a project/contract basis to biotechnology and pharmaceutical sponsors, with pricing based on study scope, complexity, and duration.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Biotrial is a full-service Contract Research Organization (CRO) that provides integrated drug development services spanning non-clinical pharmacology, clinical development (Phase I trials with healthy volunteers and patients), bioanalysis, biometrics, and Core Lab services (EEG, ECG, medical imaging). The company operates purpose-built Phase I clinical pharmacology units in France (150 beds) and the USA (110 beds) and serves biotechnology and pharmaceutical sponsors worldwide.

Product overview

Biotrial Neuroscience is a Contract Research Organization (CRO) providing integrated drug development services across the pharmaceutical pipeline. The company operates as a platform of interconnected service divisions: Nonclinical Services delivers preclinical safety and oncology models; Core Lab Services provides specialized CNS, cardiac, and imaging assessments; Clinical Services manages Phase I-IV trials; Data Science Services offers pharmacometric modeling and AI-powered in-silico trials; Bioanalysis Services handles sample analysis and storage; and Biometrics Services manages EDC, biostatistics, and medical writing. These services work together to provide sponsors with end-to-end clinical research capabilities from early discovery through regulatory submission.

Differentiator

Problem solved

Functional benefit

Products and services

• Nonclinical Services Comprehensive preclinical testing services including Safety, Efficacy, PK Studies, Model Development, and In Vitro and In Vivo Models for Oncology research, offered to biotechnology and pharmaceutical sponsors.
• Core Lab Services Specialized laboratory services including Central EEG & Polysomnography, CNS Testing, Cardiac Safety & ECG, QT Investigations, and Medical Imaging for clinical trials.
• Clinical Services Full-service clinical trial management including Phase 1 Healthy Volunteers studies, Specialized Phase 1 studies, Oncology Trial Management, Patient Trial Management, Clinical Monitoring, Pharmacovigilance & Medical Monitoring, Pharmaceutical Affairs, and Regulatory Affairs.
• Data Science Services Advanced analytics and modeling services including Pharmacometrics & PK/PD modeling, In-Silico Trials, and Real World Data analysis using AI, NLP, deep learning, and generative AI algorithms.
• Bioanalysis Services Comprehensive bioanalytical services including Non-GLP & Discovery Services, Method Development & Method Transfer, GLP Non-clinical Sample Analysis, Quantitative Bioanalysis using LC-MS MS, and Sample Management & Storage.
• Biometrics Services Clinical data management services including Electronic Data Capture (EDC) using Medidata Rave and Clincase platforms, Data Management, Biostatistics, and Medical Writing.

Quantifiable outcome

• Industry-leading turnaround times for bioanalysis including first-to-file studies
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability5 records

Feature6 records

Partnerships

One partnership is on record.

• Pareann BiotechnologiescoreStrategic or Co-development Partner · 1 March 2026Biotrial has strengthened its partnership with Pareann Biotechnologies to expand preclinical and clinical capabilities. The collaboration focuses on development of a novel preclinical lung cancer model combining controlled microbiome, humanized immune system, and tumor cells derived from patients (MESHCAP project).

Scale indicators5 records

Recent moves3 records

Expansion highlights4 records

Direct peers

• Celerion: Celerion is a closely comparable early-phase clinical CRO specializing in Phase I studies, bioanalytical services, and clinical pharmacology. Both operate dedicated Phase I clinical pharmacology units and emphasize bioanalytical capabilities with similar sponsor profiles.
• Altasciences: Altasciences is a mid-sized full-service CRO with strong early-phase clinical and bioanalytical capabilities, including purpose-built Phase I facilities. Directly comparable in service mix, therapeutic focus (CNS, oncology), and target customer base of biotech and pharma sponsors.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-market CRO with deep CNS, oncology, and cardiometabolic expertise. Comparable to Biotrial in therapeutic area specialization, Phase I/early-phase capabilities, and mid-sized positioning relative to mega-CROs.
• Medpace: Medpace is a mid-to-large CRO with strong Phase I/early-phase capabilities and therapeutic specialization across multiple areas including oncology and CNS. Similar full-service clinical development model targeting biotech and pharma sponsors.

Broad incumbents

• ICON plc: ICON is one of the largest global CROs offering end-to-end drug development services including Phase I. Comparable in service breadth and sponsor overlap, but operates at a substantially larger scale across more geographies.
• Parexel International: Parexel is a large global full-service CRO with comparable Phase I through Phase IV capabilities. Overlaps significantly with Biotrial in CNS, oncology, and cardiovascular therapeutic areas but operates at materially larger scale.
• Syneos Health: Syneos Health is a large global CRO and commercialization provider offering clinical development services including early-phase trials. Comparable in full-service positioning but with a much broader geographic and operational footprint.
• Eurofins Scientific: Eurofins operates a large bioanalytical and central laboratory business serving pharma and biotech sponsors. Overlaps with Biotrial's bioanalysis and central lab offerings through its Pharma Services division, with much broader scale.
• PPD (Thermo Fisher Scientific): PPD, now part of Thermo Fisher, is one of the world's largest CROs offering end-to-end clinical development services. Comparable in early-phase to Phase IV capabilities but at vastly larger scale and geographic reach.
• Charles River Laboratories: Charles River operates Discovery & Safety Assessment, Manufacturing, and CDMO services with significant preclinical CRO overlap with Biotrial's Non-clinical Services division. Comparable in pharma/biotech sponsor base but broader in scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biotrial

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about biotrial neuroscience